Progression of Coronary Calcium Detected on Routine Chest CT Enhances Cardiovascular Risk Assessment in Individuals with Inflammatory Bowel Disease: Findings from a Multicenter Study - Report - MDSpire

Progression of Coronary Calcium Detected on Routine Chest CT Enhances Cardiovascular Risk Assessment in Individuals with Inflammatory Bowel Disease: Findings from a Multicenter Study

  • By

  • Qi Zhang

  • Yanxun Su

  • Chenyao Song

  • Ting Xu

  • Wenyan Liu

  • Jiaxin Cao

  • Binwei Guo

  • Lingjie Wang

  • Huajie Yue

  • Cheng Xu

  • Xuhui Zhao

  • Sijin Li

  • April 17, 2026

  • 0 min

Share

Progression of Coronary Calcium Enhances Cardiovascular Risk Assessment in IBD

Overview

Enhance clarity on the significance of CAC assessment in IBD patients compared to traditional risk factors.

Background

Patients with inflammatory bowel disease (IBD) are at an increased risk for atherosclerotic cardiovascular disease (ASCVD), which is often underestimated by traditional risk factors. Chronic inflammation associated with IBD contributes to this elevated risk, necessitating improved risk assessment tools. The study explores the prognostic value of CAC progression in IBD patients, aiming to refine cardiovascular risk stratification.

Data Highlights

MeasureValue
MACE Incidence59 patients
AF Incidence41 patients
CAC Progression Rate27.6%
HR for MACE (CAC Progression)7.41 (P < 0.001)
C-index Improvement0.67 to 0.73
NRI Improvement0.22 (P < 0.001)

Key Findings

  • CAC progression occurred in 27.6% of IBD patients and predicted MACE with a hazard ratio of 7.41 (P < 0.001).
  • Graded risk was observed with relative HR of 10.31, absolute HR of 8.14, and incident HR of 5.22 (all P < 0.001).
  • Adding CAC progression to conventional risk factors improved the C-index from 0.67 to 0.73.
  • Baseline CAC provided only modest predictive value (C-index 0.67 to 0.68; NRI 0.04, P = 0.021).
  • CAC progression was also associated with an increased risk of incident atrial fibrillation.

Clinical Implications

The findings underscore the importance of incorporating CAC progression into cardiovascular risk assessments for patients with IBD. Clinicians should consider routine chest CT scans as a valuable tool for identifying patients at higher risk for cardiovascular events, potentially guiding preventive strategies.

Conclusion

Reiterate the potential impact of revised risk stratification on patient outcomes.

References

  1. The ASCO Post, 2020 -- Predicting Cardiovascular Disease Risk Via Routine CT Scans in Women With Breast Cancer
  2. Clinical Research in Cardiology, 2024 -- Cardiovascular MRI Identifies Myocardial Involvement in Patients with Active Inflammatory Bowel Disease
  3. European Radiology, 2025 -- CT-derived attenuation index of peribowel fat tissue as a predictor of disease advancement in patients with inflammatory bowel disease
  4. PubMed -- Association between inflammatory bowel disease, current therapies, and cardiovascular events: a review and meta-analysis of data from 2.2 million individuals
  5. 2026 Guideline on the Management of Dyslipidemia - Professional Heart Daily | American Heart Association
  6. European Radiology — Association of high-risk CT coronary artery plaque features with major adverse cardiovascular events: a prespecified secondary analysis of the DISCHARGE trial
  7. Patients with inflammatory bowel disease and cardiovascular disease risk
  8. 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia
  9. Incremental Prognostic Value of Coronary Artery Calcium Progression within a Large Community-Benefit Calcium Score Registry - ScienceDirect

Original Source(s)

Related Content